Drug Profile
Research programme: nerve growth factor therapeutics - Chiesi
Alternative Names: hNGF P61S; hNGF P61SR100E; hNGF R100E; NGF P61SR100ELatest Information Update: 04 Sep 2023
Price :
$50
*
At a glance
- Originator Chiesi
- Class Nerve growth factors
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 04 Sep 2023 Discontinued - Preclinical for Unspecified in Italy (unspecified route) (Chiesi website, September 2023)
- 28 Jul 2020 No recent reports of development identified for preclinical development in Unspecified in Italy
- 15 Jun 2016 Preclinical trials in Undefined indication in Italy (unspecified route)